Finanza

Horizon Therapeutics Public Limited Company: Oppenheimer mantiene la raccomandazione Buy

Horizon Therapeutics Public Limited Company: Oppenheimer mantiene la raccomandazione Buy

Horizon Therapeutics Public


FIMA2632# 2022-08-04T16:01:19+02:00

Show More